Theodoros Xenohristos, the Chief Concept Officer of $CAVA, sold 965 shares of the company on 01-21-2026 for an estimated $65,050. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.3% of their shares of this class of stock. Following this trade, they now own 333,244 shares of this class of $CAVA stock.
$CAVA Insider Trading Activity
$CAVA insiders have traded $CAVA stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CAVA stock by insiders over the last 6 months:
- BRETT SCHULMAN (CEO and President) has made 1 purchase buying 150 shares for an estimated $7,346 and 1 sale selling 21,650 shares for an estimated $1,459,426.
- KENNETH ROBERT BERTRAM (CLO & Secretary) has made 0 purchases and 3 sales selling 8,633 shares for an estimated $486,411.
- TRICIA K. TOLIVAR (Chief Financial Officer) sold 2,204 shares for an estimated $148,571
- KELLY COSTANZA (Chief People Officer) sold 1,702 shares for an estimated $114,731
- THEODOROS XENOHRISTOS (Chief Concept Officer) sold 965 shares for an estimated $65,050
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CAVA Hedge Fund Activity
We have seen 297 institutional investors add shares of $CAVA stock to their portfolio, and 276 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JENNISON ASSOCIATES LLC removed 6,392,808 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $386,189,531
- CAPITAL INTERNATIONAL INVESTORS added 2,169,553 shares (+105.4%) to their portfolio in Q3 2025, for an estimated $131,062,696
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 1,888,723 shares (+inf%) to their portfolio in Q3 2025, for an estimated $114,097,756
- ALLIANCEBERNSTEIN L.P. added 1,600,630 shares (+118.3%) to their portfolio in Q3 2025, for an estimated $96,694,058
- CAPITAL RESEARCH GLOBAL INVESTORS added 1,469,758 shares (+28.5%) to their portfolio in Q3 2025, for an estimated $88,788,080
- POINT72 ASSET MANAGEMENT, L.P. removed 1,097,644 shares (-90.1%) from their portfolio in Q3 2025, for an estimated $66,308,674
- CITADEL ADVISORS LLC added 1,071,538 shares (+32639.0%) to their portfolio in Q3 2025, for an estimated $64,731,610
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CAVA Revenue
$CAVA had revenues of $292.2M in Q3 2025. This is an increase of 19.86% from the same period in the prior year.
You can track CAVA financials on Quiver Quantitative's CAVA stock page.
$CAVA Analyst Ratings
Wall Street analysts have issued reports on $CAVA in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Telsey Advisory Group issued a "Outperform" rating on 01/09/2026
- Truist Securities issued a "Buy" rating on 01/08/2026
- Argus Research issued a "Buy" rating on 11/13/2025
- Stifel issued a "Buy" rating on 11/05/2025
- Keybanc issued a "Overweight" rating on 11/05/2025
- RBC Capital issued a "Outperform" rating on 10/09/2025
- TD Cowen issued a "Buy" rating on 08/13/2025
To track analyst ratings and price targets for $CAVA, check out Quiver Quantitative's $CAVA forecast page.
$CAVA Price Targets
Multiple analysts have issued price targets for $CAVA recently. We have seen 16 analysts offer price targets for $CAVA in the last 6 months, with a median target of $72.5.
Here are some recent targets:
- Brian Harbour from Morgan Stanley set a target price of $80.0 on 01/20/2026
- Sarang Vora from Telsey Advisory Group set a target price of $85.0 on 01/09/2026
- Nick Setyan from Mizuho set a target price of $64.0 on 01/09/2026
- Jake Bartlett from Truist Securities set a target price of $78.0 on 01/08/2026
- Jeffrey Bernstein from Barclays set a target price of $70.0 on 01/07/2026
- Dennis Geiger from UBS set a target price of $66.0 on 01/06/2026
- Danilo Gargiulo from Bernstein set a target price of $75.0 on 01/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
